Lina Benhassine1, Sae-Yeon Won2,3, Natalie Filmann4, Ümniye Balaban4, Marcel A Kamp5, Gerhard Marquardt2, Markus Czabanka2, Christian A Senft2,5, Volker Seifert2, Nazife Dinc2,5. 1. Department of Neurosurgery, Goethe University Hospital Frankfurt, Schleusenweg 16, 60528, Frankfurt a.M., Germany. Lina.Benhassine@kgu.de. 2. Department of Neurosurgery, Goethe University Hospital Frankfurt, Schleusenweg 16, 60528, Frankfurt a.M., Germany. 3. Department of Neurosurgery, University Hospital Rostock, Rostock, Germany. 4. Department of Biostatistics, Goethe University Hospital Frankfurt, Frankfurt, Germany. 5. Department of Neurosurgery, Friedrich Schiller University Hospital Jena, Jena, Germany.
Abstract
OBJECTIVE: Intracranial haemorrhage (ICH) is associated with permanent neurological disability resulting in deterioration of the quality of life (QoL). Our study assesses QoL in patients with ruptured arteriovenous malformation (AVM) in long-term follow-up at least five years after ICH and compares their QoL with the QoL of patient with non-ruptured AVM. METHODS: Using the Quality of Life Scale (QOLS), the Patient Health Questionnaire (PHQ-9) for depressive symptoms, and the socioeconomic status (SES), a prospective assessment was performed. The modified Rankin Scale (mRS) was assessed for outcome. RESULTS: Of 73 patients, 42 (57.5%) had ruptured (group 1) and 31 (42.5%) a non-ruptured AVM (group 2). Mean follow-up time was 8.6 ± 3.9 years (8.5 ± 4.2 years in group 1 and 8.9 ± 3.7 years in group 2). Favourable outcome (mRS 0-1) was assessed in 60 (83.3%) and unfavourable in 12 (16.7%) patients. Thirty-one of 42 patients (73.8%) in group 1 and 29 of 30 patients in group 2 (96.7%) had favourable outcomes. Mean QOLS was 85.6 ± 14.1 (group 1 86.1 ± 15.9, group 2 84.9 ± 11.4). Patients in group 1 did not show a significant difference in QoL compared to patients in group 2 (p = 0.23). Additional analyses in group 2 (rho = - 0.73; p < 0.01) and in untreated AVM patients (rho = - 0.81; p < 0.01) showed a strong correlation between QOLS and PHQ-9. CONCLUSION: Long-term follow-up showed no difference in the QoL between patients with and without ICH caused by brain AVM. Outcome- and QoL-scores were high in both groups. Further studies are necessary to evaluate depression and anxiety symptoms in patients with AVM.
OBJECTIVE: Intracranial haemorrhage (ICH) is associated with permanent neurological disability resulting in deterioration of the quality of life (QoL). Our study assesses QoL in patients with ruptured arteriovenous malformation (AVM) in long-term follow-up at least five years after ICH and compares their QoL with the QoL of patient with non-ruptured AVM. METHODS: Using the Quality of Life Scale (QOLS), the Patient Health Questionnaire (PHQ-9) for depressive symptoms, and the socioeconomic status (SES), a prospective assessment was performed. The modified Rankin Scale (mRS) was assessed for outcome. RESULTS: Of 73 patients, 42 (57.5%) had ruptured (group 1) and 31 (42.5%) a non-ruptured AVM (group 2). Mean follow-up time was 8.6 ± 3.9 years (8.5 ± 4.2 years in group 1 and 8.9 ± 3.7 years in group 2). Favourable outcome (mRS 0-1) was assessed in 60 (83.3%) and unfavourable in 12 (16.7%) patients. Thirty-one of 42 patients (73.8%) in group 1 and 29 of 30 patients in group 2 (96.7%) had favourable outcomes. Mean QOLS was 85.6 ± 14.1 (group 1 86.1 ± 15.9, group 2 84.9 ± 11.4). Patients in group 1 did not show a significant difference in QoL compared to patients in group 2 (p = 0.23). Additional analyses in group 2 (rho = - 0.73; p < 0.01) and in untreated AVM patients (rho = - 0.81; p < 0.01) showed a strong correlation between QOLS and PHQ-9. CONCLUSION: Long-term follow-up showed no difference in the QoL between patients with and without ICH caused by brain AVM. Outcome- and QoL-scores were high in both groups. Further studies are necessary to evaluate depression and anxiety symptoms in patients with AVM.
Authors: Nazife Dinc; Johannes Platz; Stephanie Tritt; Johanna Quick-Weller; Michael Eibach; Robert Wolff; Joachim Berkefeld; Volker Seifert; Gerhard Marquardt Journal: J Clin Neurosci Date: 2018-07 Impact factor: 1.961
Authors: Marco Cenzato; Edoardo Boccardi; Ettore Beghi; Peter Vajkoczy; Istvan Szikora; Enrico Motti; Luca Regli; Andreas Raabe; Shalva Eliava; Andreas Gruber; Torstein R Meling; Mika Niemela; Alberto Pasqualin; Andrey Golanov; Bengt Karlsson; Andras Kemeny; Roman Liscak; Bodo Lippitz; Matthias Radatz; Alessandro La Camera; René Chapot; Civan Islak; Laurent Spelle; Alberto Debernardi; Elio Agostoni; Martina Revay; Michael K Morgan Journal: Acta Neurochir (Wien) Date: 2017-04-07 Impact factor: 2.216
Authors: Jae H Choi; Henning Mast; Robert R Sciacca; Andreas Hartmann; Alexander V Khaw; Jay P Mohr; Ralph L Sacco; Christian Stapf Journal: Stroke Date: 2006-04-13 Impact factor: 7.914
Authors: Ching-Jen Chen; Dale Ding; Colin P Derdeyn; Giuseppe Lanzino; Robert M Friedlander; Andrew M Southerland; Michael T Lawton; Jason P Sheehan Journal: Neurology Date: 2020-10-01 Impact factor: 9.910